ArticleJAC-antimicrobial resistance2026

Clinical outcomes of dalbavancin versus standard therapy for non-severe skin and soft-tissue infections as well as bone and joint infections: a retrospective observational study.

Taito Kitano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.